Loading viewer...
investor_presentation
Format: PDF investor_presentation
Investor presentation covering first-half 2019 financial results and FY19 outlook, presented on 20 November 2018. Includes summary of 1H19 performance, detailed financial results, and forward guidance from CEO Skander Malcolm.
earnings
19 Pages
New Zealand King Salmon FY23 Financial Results Investor Presentation
investor_presentationinvestor_presentation
24 Pages
New Zealand King Salmon Investments Limited
Basilea Pharmaceutica 2020 Investment Conference Presentation
investor_presentationinvestor_presentation
26 Pages
Basilea Pharmaceutica International Ltd.